# Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)

> **NCT00211380** · NA · TERMINATED · sponsor: **Louisiana State University Health Sciences Center Shreveport** · enrollment: 8 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** aripiprazole

## Key facts

- **NCT ID:** NCT00211380
- **Lead sponsor:** Louisiana State University Health Sciences Center Shreveport
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-08
- **Primary completion:** 2006-02
- **Final completion:** 2006-02
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Recruitment was too difficult
- **Last updated:** 2011-09-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00211380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00211380, "Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00211380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*